Jacqueline M Diaz Albert - FDA Investigator Report

Overview Statistics

96
Total Inspections
82
Total 483s Issued
0
Warning Letters Issued

Inspection Details

Longest Inspection: 38 days
Shortest Inspection: 1 days
Average Length: 6.7 days

Discover the bigger picture. This is just the tip of the iceberg.

Gain access to comprehensive analysis, detailed reports, AI assistant, and much more.

Schedule a Demo

Jacqueline M Diaz Albert's Recent Inspections

DateCompanyCityCountryFEI Number483
2022-03-04Spark Therapeutics, Inc.PhiladelphiaUnited States3011194531
2021-12-07Grifols Diagnostic Solutions Inc.EmeryvilleUnited States1000124057
2021-11-09Nelson Laboratories, LLCSalt Lake CityUnited States3000233845
2021-09-17Janssen Pharmaceuticals Inc.RaritanUnited States2211100
2021-08-31Jubilant HollisterStier LLCSpokaneUnited States3010477
2021-07-30Immucor, Inc.Peachtree CornersUnited States1034569
2021-06-16AVEXISLibertyvilleUnited States3012983541
2020-02-27LifeSouth Community Blood Centers, IncGainesvilleUnited States3003707120
2019-11-26Wyeth Pharmaceutical Division of Wyeth Holdings LLCSanfordUnited States1000110954
2019-10-18Indivior Manufacturing LLCRaleighUnited States3005208599

Sign Up to get the complete report.

Download 483s and EIRs for Jacqueline M Diaz Albert

Jacqueline M Diaz Albert - Co-Inspectors

Jacqueline M Diaz Albert's Active Locations

  • United States
  • United Kingdom
  • France
  • Belgium
  • Germany
  • Italy
  • Canada
  • Switzerland
  • Ireland
  • Austria
  • Denmark
  • Sweden
  • Spain

Jacqueline M Diaz Albert's Year-wise Inspection Count

  • 2008:9 inspections
  • 2009:7 inspections
  • 2010:4 inspections
  • 2011:11 inspections
  • 2012:8 inspections
  • 2013:7 inspections
  • 2014:8 inspections
  • 2015:5 inspections
  • 2016:4 inspections
  • 2017:7 inspections
  • 2018:10 inspections
  • 2019:8 inspections
  • 2020:1 inspections
  • 2021:6 inspections
  • 2022:1 inspections
Last Updated: 2025-05-14 06:11:22